10-67539614-T-G

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_013266.4(CTNNA3):​c.348A>C​(p.Pro116Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0193 in 1,613,772 control chromosomes in the GnomAD database, including 408 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.016 ( 23 hom., cov: 32)
Exomes 𝑓: 0.020 ( 385 hom. )

Consequence

CTNNA3
NM_013266.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -5.40

Publications

7 publications found
Variant links:
Genes affected
CTNNA3 (HGNC:2511): (catenin alpha 3) This gene encodes a protein that belongs to the vinculin/alpha-catenin family. The encoded protein plays a role in cell-cell adhesion in muscle cells. Mutations in this gene are associated with arrhythmogenic right ventricular dysplasia, familial 13. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]
CTNNA3 Gene-Disease associations (from GenCC):
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • arrhythmogenic right ventricular dysplasia 13
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • congenital heart disease
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 10-67539614-T-G is Benign according to our data. Variant chr10-67539614-T-G is described in ClinVar as Benign. ClinVar VariationId is 220770.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0157 (2388/152254) while in subpopulation SAS AF = 0.0353 (170/4814). AF 95% confidence interval is 0.031. There are 23 homozygotes in GnomAd4. There are 1094 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 2388 AD,Unknown gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_013266.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CTNNA3
NM_013266.4
MANE Select
c.348A>Cp.Pro116Pro
synonymous
Exon 4 of 18NP_037398.2
CTNNA3
NM_001127384.3
c.348A>Cp.Pro116Pro
synonymous
Exon 4 of 18NP_001120856.1
CTNNA3
NM_001291133.2
c.384A>Cp.Pro128Pro
synonymous
Exon 5 of 9NP_001278062.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CTNNA3
ENST00000433211.7
TSL:1 MANE Select
c.348A>Cp.Pro116Pro
synonymous
Exon 4 of 18ENSP00000389714.1
CTNNA3
ENST00000682758.1
c.348A>Cp.Pro116Pro
synonymous
Exon 5 of 19ENSP00000508047.1
CTNNA3
ENST00000684154.1
c.348A>Cp.Pro116Pro
synonymous
Exon 4 of 18ENSP00000508371.1

Frequencies

GnomAD3 genomes
AF:
0.0157
AC:
2390
AN:
152136
Hom.:
23
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00994
Gnomad AMI
AF:
0.0406
Gnomad AMR
AF:
0.0167
Gnomad ASJ
AF:
0.0135
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0355
Gnomad FIN
AF:
0.00301
Gnomad MID
AF:
0.0255
Gnomad NFE
AF:
0.0205
Gnomad OTH
AF:
0.0158
GnomAD2 exomes
AF:
0.0171
AC:
4281
AN:
250900
AF XY:
0.0185
show subpopulations
Gnomad AFR exome
AF:
0.00991
Gnomad AMR exome
AF:
0.0121
Gnomad ASJ exome
AF:
0.0135
Gnomad EAS exome
AF:
0.000218
Gnomad FIN exome
AF:
0.00273
Gnomad NFE exome
AF:
0.0199
Gnomad OTH exome
AF:
0.0232
GnomAD4 exome
AF:
0.0197
AC:
28775
AN:
1461518
Hom.:
385
Cov.:
30
AF XY:
0.0204
AC XY:
14816
AN XY:
727070
show subpopulations
African (AFR)
AF:
0.00954
AC:
319
AN:
33450
American (AMR)
AF:
0.0128
AC:
574
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.0135
AC:
352
AN:
26124
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39694
South Asian (SAS)
AF:
0.0349
AC:
3011
AN:
86252
European-Finnish (FIN)
AF:
0.00337
AC:
180
AN:
53412
Middle Eastern (MID)
AF:
0.0401
AC:
231
AN:
5764
European-Non Finnish (NFE)
AF:
0.0206
AC:
22906
AN:
1111754
Other (OTH)
AF:
0.0198
AC:
1198
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
1397
2795
4192
5590
6987
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
862
1724
2586
3448
4310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0157
AC:
2388
AN:
152254
Hom.:
23
Cov.:
32
AF XY:
0.0147
AC XY:
1094
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.00994
AC:
413
AN:
41562
American (AMR)
AF:
0.0167
AC:
255
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.0135
AC:
47
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5178
South Asian (SAS)
AF:
0.0353
AC:
170
AN:
4814
European-Finnish (FIN)
AF:
0.00301
AC:
32
AN:
10616
Middle Eastern (MID)
AF:
0.0240
AC:
7
AN:
292
European-Non Finnish (NFE)
AF:
0.0205
AC:
1393
AN:
68014
Other (OTH)
AF:
0.0156
AC:
33
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
121
241
362
482
603
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0189
Hom.:
14
Bravo
AF:
0.0161
Asia WGS
AF:
0.0230
AC:
79
AN:
3478
EpiCase
AF:
0.0218
EpiControl
AF:
0.0222

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Apr 10, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:2
Sep 25, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Arrhythmogenic right ventricular dysplasia 13 Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
1.4
DANN
Benign
0.59
PhyloP100
-5.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.22
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.22
Position offset: -6

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61749224; hg19: chr10-69299372; API